HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beta-[1-Phenyl-5-bis(beta-chloroethyl)-amino-benzimidazolyl-(2)]-DL-alanine (ZIMET 3164): an immunosuppressant without marked anti-cancer effect.

Abstract
ZIMET 3164 inhibited the growth of sarcoma 180 P, sarcoma 180 G, and Walker 256 carcinosarcoma, but was unable to prolong the survival time of mice bearing Ehrlich ascites carcinoma or the leukaemias L 1210 and LAJ I to a worthwhile extent. The primary and secondarantly suppressed in mice. The drug exerted maximum effect when given on days--2 to +2 relative to antigenic stimulus. Administration exclusively prior to immunization induced only moderate immunosuppression while injection afterwards failed to affect the primary response at all, suggesting that the drug interfers with the afferent limb of immune response. In general, ZIMET 3164 proved to be half as effective as cyclophosphamide, but more effective than chlorambucil.
AuthorsJ Güttner, W Gutsche, W Zchiesche, K Wohlrabe, W Jungstand, W Ozegowski, D Krebs, G Röppnack
JournalAgents and actions (Agents Actions) Vol. 9 Issue 5-6 Pg. 521-6 (Dec 1979) ISSN: 0065-4299 [Print] Switzerland
PMID546175 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Benzimidazoles
  • Immunosuppressive Agents
  • Nitrogen Mustard Compounds
  • Chlorambucil
  • IMET 3146
  • Cyclophosphamide
Topics
  • Animals
  • Antibody Formation (drug effects)
  • Antineoplastic Agents
  • Benzimidazoles (pharmacology, toxicity)
  • Chlorambucil (pharmacology)
  • Cyclophosphamide (pharmacology)
  • Immunosuppressive Agents (toxicity)
  • Lethal Dose 50
  • Mice
  • Mice, Inbred Strains
  • Neoplasm Transplantation
  • Neoplasms, Experimental (drug therapy)
  • Nitrogen Mustard Compounds (pharmacology, toxicity)
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: